Porter Leslie Announced as President of Ametros
Thursday, July 13, 2017 | 1025 | 0 | min read
Contact: Melissa Wright
FOR IMMEDIATE RELEASE
PORTER LESLIE ANNOUNCED AS THE PRESIDENT OF AMETROS
July 7, 2017
WILMINGTON, Mass. – Ametros, the industry leader in post-settlement medical administration, announced the promotion of Porter Leslie to President of Ametros. The announcement was made by Marques Torbert, CEO of Ametros.
“Porter has a track record of executing strategic initiatives with remarkable success,” remarked Marques, “In his new role, he will help the company get closer to achieving its mission of revolutionizing the insurance and healthcare services industry by developing more cutting-edge products and innovative services to benefit our clients and members.”
Porter joined Ametros in 2015 and in his previous role as Chief Strategy Officer, had been instrumental in driving growth and change across various disciplines within the company, including IT, marketing, new product development, and strategic partnerships.
“We have built a phenomenal team with close to 50 employees, who provide nationwide support for anyone who needs help managing their healthcare after settlement,” commented Porter. “I feel privileged to be asked to lead some of the smartest and dedicated minds in the industry. There is no limit to what we can accomplish together.”
Ametros is changing the way individuals navigate healthcare by providing them with the tools and support necessary to make savvy decisions on how to spend their medical funds. Ametros' team works closely with patients, insurers, employers, attorneys, medical providers and Medicare to create a seamless experience for their clients. Their depth of expertise in the Medicare Set Aside, property and casualty insurance, healthcare, legal, financial and software industries positions them to offer the best solutions in the marketplace. Their flagship products, CareGuard and Amethyst, are revolutionizing the way funds from insurance claim settlements are administered after settlement, for Medicare Set Aside accounts and any other medical allocation. Ametros is backed by Clarion Capital Partners, LLC, a New York based private equity firm. For more information, visit www.ametroscards.com.